Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, announced the first patients have been dosed in its Phase 2a clinical trial evaluating the safety and efficacy of PP405, a novel topical small molecule, for the treatment of androgenetic alopecia (pattern baldness).
CarbonQuest, a leading distributed carbon capture technology provider, announced the initial closing on its Series A funding from Riverbend Energy Group. The funding will enable CarbonQuest to offer its Distributed Carbon Capture™ technology to a broader range of carbon emitters and accelerate market penetration of its cost-effective and economically viable solution.
Defense Tech Startup Anduril Industries raises $1.5 billion in series F round funding to hyperscale defense manufacturing. With this money, Anduril will be able...
Datch has successfully closed its $15M Series A funding round via an extension led by Third Prime with support from existing investors including Blackhorn Ventures, Blue Bear Capital, and Susquehanna International Group.
Nob Hill Therapeutics, an early-stage pulmonary medical device and therapeutics company, has raised the first close of a $3 million Series A financing round. The round was led by new investor Tramway Venture Partners and included investments from TCA Venture Group and VIC Technology Venture Development (which founded NHT).
Abnormal Security, the leader in AI-native human behavior security, announced the close of its Series D funding round, with total expected proceeds of $250 million at a $5.1 billion valuation. The current round brings the total expected proceeds to $546 million and is led by Wellington Management, with participation from existing investors Greylock Partners, Menlo Ventures, Insight Partners and CrowdStrike Falcon Fund.
H3X, manufacturer of high power density electric motors, raised $20 million in Series A funding round led by Infinite Capital, with participation from Hanwha Asset Management, Cubit Capital, Origin Ventures, Industrious Ventures, Venn10 Capital, Lockheed Martin Ventures, Metaplanet, Liquid 2 Ventures, and TechNexus.
Existing and emerging viral threats endanger all of us, but people with impaired immune systems are at substantially greater risk. Apple Tree Partners (ATP), a leader in life sciences venture capital, unveiled Red Queen Therapeutics, a clinical-stage biotechnology company developing novel antiviral treatments for the general population and especially for immunocompromised patients who are at increased risk of serious illness or death from common and emerging viral pathogens.
Seeq, a leader in industrial analytics, AI, and monitoring, announced today it has closed a $50 million Series D funding round led by leading global investment firm Sixth Street Growth, with participation from existing investors including Insight Partners, Altira Group, Second Avenue Partners, and Saudi Aramco Energy Ventures.
NanoHive Medical, a leader in 3D-printed titanium spinal interbody fusion devices, announces a $7M Series C financing to capitalise on the company’s rapid growth and a priority on company-building to profitability. Outcome Capital served as a strategic and financial advisor to NanoHive.
